ARCHIVES

Two Second-Line CML Drugs Work Front-Line, Studies Find

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

Manipulating The Therapeutic Index Clinical Trials Goal: Hellman

June 13, 1980

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers

November 21, 2014

In Brief: While House Floats Healy’s Name For NIH Post; USC To Enhance Norris Center With NCI Grants

September 14, 1990

ASCO Supports CT Scans For Colorectal Screening

November 25, 2005

NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years

December 6, 1996